Sakar Healthcare - Standalone Q3- Net profit falls to Rs. 1.79 crore against Rs.2.20 crore in Q3-FY20
Sakar Healthcare– Standalone Q3-FY21 Revenue reached Rs. 27.05 crore against Rs.22.48 crore in Q3-FY20
Company : Sakar Healthcare Limited
Sakar Healthcare announced its Standalone and consolidated financial results for the quarter and period ended on 31st December, 2020.
Financials for Standalone Q3 at Sakar Healthcare in FY20-21 are as follows:
- Revenue reached Rs. 27.05 crore while previous year corresponding period it was Rs. 22.48 crore. - Net profit falls to Rs. 1.79 crore against Rs.2.20 crore in a year ago period. - Earning per share was Rs. 1.20 against Rs. 1.48 in a year ago period.Standalone financials for the 9 months period ended on 31st December 2020 at Sakar Healthcare are as follows:
- Revenue was Rs. 73.81 crore whereas in the last year same period it was Rs. 65.70 crore. - Net profit was Rs.8.94 crore against Rs. 6.76 crore in a year ago period - Earning per share was Rs. 5.96 against Rs. 4.52 in the corresponding period previous year.Standalone annual revenue in FY19-20 reached Rs. 84.99 crore with net profit of Rs. 9.62 crore and Earning per share was Rs.6.40 at Sakar Healthcare.
Following are the consolidated Q3 financials at Sakar Healthcare in FY20-21: - Revenue reached Rs. 27.05 crore whereas in the previous quarter it was Rs. 26.37 crore - PAT falls to Rs. 1.79 crore against Rs. 4.56 crore in Q2. - EPS was Rs. 1.20 while in the preceding quarter it was profit of Rs.3.04 per share.Consolidated annual revenue at Sakar Healthcare in FY20-21 reached Rs. 73.81 crore with Net profit of Rs. 8.94 crore and Earning per share was Rs. 5.96.
STANDALONE FINANCIAL RESULTS FOR THE QUARTER & NINE MONTHS ENDED DECEMBER 31,2020Quarter Ended |
Quarter Ended |
Nine Months Ended | Nine Months Ended | Year Ended |
|
---|---|---|---|---|---|
31/12/2020 | 31/12/2019 | 31/12/2020 | 31/12/2019 | 2019-2020 | |
Income Statement | |||||
Revenue | 2679.34 | 2226.38 | 7305.79 | 6471.99 | 8298.03 |
Other Income | 26.60 | 21.96 | 76.16 | 98.89 | 201.68 |
Total Income | 2705.94 | 2248.34 | 7381.95 | 6570.88 | 8499.71 |
Expenditure | 2293.5 | 1764.69 | 5752.22 | 4979.22 | 6343.78 |
Interest | 79.81 | 58.90 | 204.83 | 160.56 | 225.26 |
PBDT | 332.63 | 424.75 | 1424.9 | 1431.1 | 1930.67 |
Depreciation | 107.67 | 132.60 | 324.30 | 515.85 | 707.98 |
PBT | 224.96 | 292.15 | 1100.6 | 915.25 | 1222.69 |
Tax | 45.01 | 71.19 | 205.8 | 239.14 | 288.41 |
Net Profit | 179.95 | 220.96 | 894.8 | 676.11 | 962.28 |
Equity | 1496.10 | 1496.10 | 1496.10 | 1496.10 | 1496.10 |
EPS | 1.20 | 1.48 | 5.96 | 4.52 | 6.40 |
Recent Stories